Entos Pharmaceuticals Competitors and Similar CompaniesClear all
Entos Pharmaceuticals's competitors and similar companies include Enable Injections, Genentech, Ipsen and Livzon Pharmaceutical Group.
 Entos Pharmaceuticals Entos Pharmaceuticals is a company that develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system. |  Enable Injections Enable Injections is a company developing and manufacturing on-body subcutaneous drug delivery systems. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2016 | Founding Date 2010 | Founding Date 1976 | Founding Date 1929 | Founding Date 1985 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Edmonton, CA HQ | Locations Cincinnati, US HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 44 | Employees 1932% increase | Employees 18,077 | Employees 5,358 | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income €445.1m (FY, 2025) | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Enable Injections
HQ
Cincinnati, US
Employees
193↑ 2% increase
Enable Injections is a company developing and manufacturing on-body subcutaneous drug delivery systems.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company